1. Squamous cell carcinoma arising from mature cystic teratoma of the ovary: A challenging question for gynecologic oncologists.
- Author
-
Gadducci A, Guerrieri ME, and Cosio S
- Subjects
- Carcinoma, Squamous Cell diagnosis, Carcinoma, Squamous Cell therapy, Cell Transformation, Neoplastic pathology, Diagnosis, Differential, Disease Progression, Female, Humans, Medical Oncology methods, Neoplasm Staging, Ovarian Cysts therapy, Ovarian Neoplasms diagnosis, Ovarian Neoplasms therapy, Teratoma diagnosis, Teratoma therapy, Carcinoma, Squamous Cell pathology, Diagnostic Techniques, Obstetrical and Gynecological, Ovarian Cysts diagnosis, Ovarian Cysts pathology, Ovarian Neoplasms pathology, Teratoma pathology
- Abstract
Mature cystic teratomas of the ovary have an incidence of 1.2-14.2 cases per 100.000 people per year. Malignant transformation occurs in approximately 2% of the cases, and usually consists of squamous cell carcinoma. The preoperative detection is difficult and the diagnostic accuracy of ultrasound, magnetic resonance imaging, and computed tomography is debated. The diagnosis is frequently made in the operating room or on final histological examination. Standard treatment consists of bilateral salpingo-oophorectomy, total hysterectomy and comprehensive surgical staging in early disease and optimal cytoreductive surgery in advanced disease. Paclitaxel/carboplatin- based chemotherapy is the most used adjuvant treatment, whereas more aggressive regimens can be adopted in patients with high tumor burden or recurrent disease. The efficacy of radiotherapy is still unproven. The prognosis is poor when the tumor has spread beyond the ovary. There are few information to provide commonly accepted guidelines for this malignancy., (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF